Citation
Casarotto, Plinio C., et al. "BDNF-TRKB Signaling System of the Dorsal Periaqueductal Gray Matter Is Implicated in the Panicolytic-like Effect of Antidepressant Drugs." European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology, vol. 25, no. 6, 2015, pp. 913-22.
Casarotto PC, Santos PC, Lucas GA, et al. BDNF-TRKB signaling system of the dorsal periaqueductal gray matter is implicated in the panicolytic-like effect of antidepressant drugs. Eur Neuropsychopharmacol. 2015;25(6):913-22.
Casarotto, P. C., Santos, P. C., Lucas, G. A., Biojone, C., Pobbe, R. L., Vilela-Costa, H. H., Joca, S. R., Guimarães, F. S., & Zangrossi, H. (2015). BDNF-TRKB signaling system of the dorsal periaqueductal gray matter is implicated in the panicolytic-like effect of antidepressant drugs. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology, 25(6), 913-22. https://doi.org/10.1016/j.euroneuro.2015.03.004
Casarotto PC, et al. BDNF-TRKB Signaling System of the Dorsal Periaqueductal Gray Matter Is Implicated in the Panicolytic-like Effect of Antidepressant Drugs. Eur Neuropsychopharmacol. 2015;25(6):913-22. PubMed PMID: 25840741.
TY - JOUR
T1 - BDNF-TRKB signaling system of the dorsal periaqueductal gray matter is implicated in the panicolytic-like effect of antidepressant drugs.
AU - Casarotto,Plinio C,
AU - Santos,Paula C dos,
AU - Lucas,Guilherme A,
AU - Biojone,Caroline,
AU - Pobbe,Roger L H,
AU - Vilela-Costa,Heloisa H,
AU - Joca,Samia R L,
AU - Guimarães,Francisco S,
AU - Zangrossi,Hélio,Jr
Y1 - 2015/03/17/
PY - 2014/04/28/received
PY - 2015/02/24/revised
PY - 2015/03/09/accepted
PY - 2015/4/5/entrez
PY - 2015/4/5/pubmed
PY - 2016/2/18/medline
KW - Antidepressants
KW - BDNF
KW - Dorsal periaqueductal gray
KW - Fluoxetine
KW - Imipramine
KW - Panic
SP - 913
EP - 22
JF - European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
JO - Eur Neuropsychopharmacol
VL - 25
IS - 6
N2 - A wealth of evidence implicates the BDNF-TRKB system in the therapeutic effects of antidepressant drugs (ADs) on mood disorders. However, little is known about the involvement of this system in the panicolytic property also exerted by these compounds. In the present study we evaluated the participation of the BDNF-TRKB system of the dorsal periaqueductal gray matter (DPAG), a core structure involved in the pathophysiology of panic disorder, in AD-induced panicolytic-like effects in rats. The results showed that short- (3 days) or long-term (21 days) systemic treatment with the tricyclic ADs imipramine, clomipramine or desipramine increased BDNF levels in the DPAG. Only longterm treatment with the selective serotonin reuptake inhibitor fluoxetine was able to increase BDNF levels in this structure. After 21-day treatment, fluoxetine and the three tricyclic ADs used also increased BDNF concentration in the hippocampus, a key area implicated in their mood-related actions. Neither in the DPAG nor hippocampus did long-term treatment with the standard anxiolytics diazepam, clonazepam or buspirone affect BDNF levels. Imipramine, both after short and long-term administration, and fluoxetine under the latter regimen, raised the levels of phosphorylated TRKB in the DPAG. Short-term treatment with imipramine or BDNF microinjection inhibited escape expression in rats exposed to the elevated T maze, considered as a panicolytic-like effect. This anti-escape effect was attenuated by the intra-DPAG administration of the TRK receptor antagonist k252a. Altogether, our data suggests that facilitation of the BDNF-TRKB system in the DPAG is implicated in the panicolytic effect of ADs.
SN - 1873-7862
UR - https://www.unboundmedicine.com/medline/citation/25840741/BDNF_TRKB_signaling_system_of_the_dorsal_periaqueductal_gray_matter_is_implicated_in_the_panicolytic_like_effect_of_antidepressant_drugs_
DB - PRIME
DP - Unbound Medicine
ER -